Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients

Research output: Contribution to journalArticlepeer-review

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)1038-1040
Number of pages3
JournalJournal of Heart and Lung Transplantation
Issue number8
StatePublished - Aug 2018

Bibliographical note

Funding Information:
R.J.C. is a member of the Abbott Speaker’s Bureau and the Medtronic Heart Failure Advisory Board, and her husband has received stock options from Medtronic due to the nature of his employment. R.J. is a member of the Abbott Speaker’s Bureau and has received Abbott research grants. The remaining authors have no conflicts of interest to disclose. This study was supported by divisional funds from the University of Minnesota.

Cite this